Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests for the early detection of multiple cancers.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk

Description

Urteste S.A. is a biotechnology company specializing in the development of non-invasive diagnostic technologies for early cancer detection. The company's core focus is on creating a method to detect multiple types of cancer from a single urine sample. This approach aims to identify malignancies at their earliest stages, potentially improving patient survival rates. The development pipeline includes diagnostic tests for various cancers, with projects such as a prototype for detecting brain tumors and planned clinical trials for a pancreatic cancer test.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-12 11:38
Zawarcie umów objęcia akcji serii G - Content (PL)
Polish 1.8 KB
2025-12-10 10:57
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish 1.6 KB
2025-12-04 17:00
Podjęte uchwały
Polish 294.0 KB
2025-12-04 17:00
Treść uchwał podjętych podczas obrad Nadzwyczajnego Walnego Zgromadzenia w dniu…
Polish 657 bytes
2025-11-28 08:18
Raport kwartalny 3Q2025
Polish 1.2 MB
2025-11-07 16:00
OPINIA ZARZĄDU uzasadniająca powody pozbawienia akcjonariuszy prawa poboru akcji
Polish 178.5 KB
2025-11-07 16:00
Projekty uchwał
Polish 229.9 KB
2025-11-07 16:00
Pełnomocnictwo udzielane przez osoby prawne do uczestnictwa
Polish 160.7 KB
2025-11-07 16:00
Pełnomocnictwo udzielane przez osoby fizyczne do uczestnictwa
Polish 156.4 KB
2025-11-07 16:00
INFORMACJE DOTYCZĄCE PRZETWARZANIA DANYCH OSOBOWYCH AKCJONARIUSZY I PEŁNOMOCNIK…
Polish 191.5 KB
2025-11-07 16:00
INFORMACJA o ogólnej liczbie akcji w Spółce Urteste S.A.
Polish 118.9 KB
2025-11-07 16:00
FORMULARZ pozwalający na wykonywanie prawa głosu przez pełnomocnika
Polish 284.9 KB
2025-11-07 16:00
Ogłoszenie Zarządu Urteste S.A.
Polish 217.3 KB
2025-11-07 16:00
Zwołanie Nadzwyczajnego Walnego Zgromadzenia na dzień 4 grudnia 2025 roku - Con…
Polish 1.5 KB
2025-11-07 10:36
Zawarcie dwóch umów inwestycyjnych dotyczących dokapitalizowania Spółki - Conte…
Polish 2.6 KB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Urteste S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Pre-clinical biotech company using AI for drug discovery and biodefense.
United States of America
RENB
LYSOGENE Logo
A former clinical-stage biotech that developed gene therapies for rare CNS diseases.
France
LYS
MaaT Pharma Logo
A clinical-stage biotech developing microbiome-based therapeutics for oncology.
France
MAAT
Matinas BioPharma Holdings, Inc. Logo
Biopharma firm developing therapeutics using its Lipid Nanocrystal (LNC) platform.
United States of America
MTNB
Matricelf Ltd. Logo
Develops autologous, patient-specific tissue implants for regenerative medicine.
Israel
MTLF
MAXCYTE, INC. Logo
A cell-engineering company with a platform for developing cell-based therapeutics.
United States of America
MXCT
Medicofarma Biotech Spolka Akcyjna Logo
R&D company developing innovative medicines, medical devices, and biotech products.
Poland
MDB
Medigene AG Logo
Develops TCR-guided immunotherapies for cancer; currently in insolvency proceedings.
Germany
MDG1
Medizen Humancare Inc Co., Ltd Logo
A research company specializing in genomic analysis for personalized healthcare.
South Korea
236340
Medpace Holdings, Inc. Logo
A global CRO providing Phase I-IV clinical development for biotech and pharma industries.
United States of America
MEDP

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.